CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas

Metabolic & Endocrine

83 drugs in pipeline from 10 companies

83

Drugs in Pipeline

10

Companies

5

Upcoming Catalysts

83

Phase 3 Trials

Upcoming Catalysts
2w
LLYPhase 3
Positive

Insulin Glargine Phase 3 Results Expected

Insulin Glargine2,749
Mar 15
CT.gov
2w
LLYPhase 3
Negative

Orforglipron Phase 3 Results Expected

Orforglipron2,749
Mar 15
CT.gov
2w
IMVTPhase 3

Batoclimab Phase 3 Results Expected

Batoclimab100
Mar 15
CT.gov
00%
2w
MDGLPhase 3

Resmetirom Phase 3 Results Expected

Resmetirom1,000
Mar 15
CT.gov
00%
3w
WXIPhase 3

Drug: 5 mg BGM0504 Administered SC Phase 3 Results Expected

Drug: 5 mg BGM0504 Administered SC537
Mar 20
CT.gov
00%
Pipeline by Phase
Phase 3
83
Related Conditions
diabetesobesitymetabolicthyroidhormoneendocrineinsulinglucosehba1cweight lossglp-1nafldnashfatty liverhyperlipidemiadyslipidemiaosteoporosis